Joint models for toxicology studies with dose-dependent number of implantations

Andrew S Allen1, Huiman X Barnhart

  • 1Department of Biostatistics and Bioinformatics and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. allen123@mc.duke.edu

Insights

This study introduces a novel joint modeling approach for toxicology studies. It accurately estimates chemical risks by considering both implantation success and fetal development, improving upon standard methods.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Biostatistics

Background:

  • Chemicals can disrupt mammalian reproduction by preventing fertilization or implantation.
  • Developmental toxicology studies often show dose-related implantation loss, which standard methods cannot fully analyze.
  • Existing methods for analyzing pre-implantation exposure effects are limited in scope and statistical rigor.

Purpose of the Study:

  • To present a joint modeling approach for estimating chemical risks in toxicology studies with pre-implantation exposure.
  • To develop a method that accounts for both implantation failure and post-implantation fetal outcomes.
  • To provide a statistically robust and adaptable framework for risk assessment in reproductive toxicology.

Main Methods:

  • A joint modeling approach is proposed, simultaneously analyzing the number of implanted fetuses and the outcome of each implanted fetus.
  • The method models both the probability of implantation and the viability of implanted fetuses.
  • The approach is demonstrated using a dominant lethal assay dataset and compared with existing methods.

Main Results:

  • The joint modeling approach provides a comprehensive estimation of chemical risk, incorporating pre-implantation effects.
  • This method allows for model fitting, explicit assumption statement, and utilization of standard statistical software.
  • Simulation studies indicate that the proposed approach exhibits lower bias and variance compared to the multiple imputation procedure.

Conclusions:

  • The joint modeling approach offers a superior method for analyzing developmental toxicology data with pre-implantation exposure.
  • This approach enhances the accuracy of risk assessment for chemicals affecting reproductive processes.
  • The presented method is statistically sound, adaptable, and offers advantages over traditional analytical techniques.

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...